Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection-Reference-Cited by-同舟云学术

Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

Published:2014-02 Issue:2 Volume:146 Page:420-429
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Everson Gregory T.,Sims Karen D.,Rodriguez-Torres Maribel,Hézode Christophe,Lawitz Eric,Bourlière Marc,Loustaud-Ratti Veronique,Rustgi Vinod,Schwartz Howard,Tatum Harvey,Marcellin Patrick,Pol Stanislas,Thuluvath Paul J.,Eley Timothy,Wang Xiaodong,Huang Shu-Pang,McPhee Fiona,Wind-Rotolo Megan,Chung Ellen,Pasquinelli Claudio,Grasela Dennis M.,Gardiner David F.

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

2. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

3. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011

4. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011

5. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents;Poordad;J Viral Hepat,2012

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning Model Validated to Predict Outcomes of Liver Transplantation Recipients with Hepatitis C: The Romanian National Transplant Agency Cohort Experience;Sensors;2023-02-14

2. Required concentration index quantifies effective drug combinations against hepatitis C virus infection;Theoretical Biology and Medical Modelling;2021-01-09

3. Required concentration index quantifies effective drug combinations against hepatitis C virus infection;2020-01-09

4. Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C;Expert Opinion on Pharmacotherapy;2020-01-08

5. Efficacy and safety of glecaprevir/pibrentasvir for chronic hepatitis C virus genotypes 1–6 infection: A systematic review and meta-analysis;International Journal of Antimicrobial Agents;2019-12